Legal Opinion
Metzler Asset Mgmt. GMBH v. Kingsley
District Court, District of Columbia
Decided March 27, 2018No. Civil Action No. 16–12101–FDSPublishedCited by 4 opinions
1Opinion of the CourtSaylor, J.
This is a putative class action involving alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of *1891934, 15 U.S.C. §§ 78j(b), 78t(a), and SEC Rule 10b-5. Lead plaintiffs Metzler Asset Management GmbH and Erste-Sparinvest Kapitalanlagegesellschaft mbH have brought suit, on behalf of a class of similarly situated persons, against biopharmaceutical company Biogen Inc. and three Biogen executives. Plaintiffs contend that class members were harmed when they purchased Biogen's common stock at prices that were artificially inflated by the company's materially misleading…
2Cases cited41 opinions
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
- Taylor v. SturgellSupreme Court of the United States · 2008
- Valerie Watterson v. Eileen PageCourt of Appeals for the First Circuit · 1993
36 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Metzler Asset Mgmt. GMBH v. KingsleyCourt of Appeals for the First Circuit · 2019
- Auctus Fund, LLC v. Nugene International, Inc.District Court, D. Massachusetts · 2021
- In re Boston Scientific Corporation Securities LitigationDistrict Court, D. Massachusetts · 2022
- Michael C. Pizzuto v. Homology Medicines, Inc.District Court, D. Massachusetts · 2024